Cargando…
Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD) is a common cause of liver disease worldwide, and is characterized by the accumulation of fat in the liver. Non-alcoholic steatohepatitis (NASH), an advanced form of NAFLD, is a leading cause of liver transplantation. Fibrosis is the histologic feature most...
Autores principales: | Yu, Amy, Cable, Carson, Sharma, Sachin, Shihan, Mahbubul H., Mattis, Aras N., Mileva, Izolda, Hannun, Yusuf A., Duwaerts, Caroline C., Chen, Jennifer Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582277/ https://www.ncbi.nlm.nih.gov/pubmed/36275798 http://dx.doi.org/10.3389/fmed.2022.881848 |
Ejemplares similares
-
Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response
por: Xu, Ruijuan, et al.
Publicado: (2016) -
CD18 deficiency improves liver injury in the MCD model of steatohepatitis
por: Pierce, Andrew A., et al.
Publicado: (2017) -
Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase
por: Bai, Aiping, et al.
Publicado: (2017) -
AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells
por: Coant, Nicolas, et al.
Publicado: (2018) -
Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress
por: Wang, Kai, et al.
Publicado: (2020)